CA2311640A1 - Polypeptides et acides nucleiques codant ces derniers - Google Patents

Polypeptides et acides nucleiques codant ces derniers Download PDF

Info

Publication number
CA2311640A1
CA2311640A1 CA002311640A CA2311640A CA2311640A1 CA 2311640 A1 CA2311640 A1 CA 2311640A1 CA 002311640 A CA002311640 A CA 002311640A CA 2311640 A CA2311640 A CA 2311640A CA 2311640 A1 CA2311640 A1 CA 2311640A1
Authority
CA
Canada
Prior art keywords
seq
sequence
atcc
polypeptide
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002311640A
Other languages
English (en)
Inventor
Kevin P. Baker
Jian Chen
Audrey Goddard
Austin L. Gurney
William I. Wood
Jean Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002408167A priority Critical patent/CA2408167A1/fr
Priority to CA002404248A priority patent/CA2404248C/fr
Publication of CA2311640A1 publication Critical patent/CA2311640A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention concerne de nouveaux polypeptides et des molécules d'acide nucléique codant ces polypeptides; des vecteurs et des cellules hôtes comprenant ces séquences d'acide nucléique, des molécules de polypeptides chimériques comprenant les polypeptides de cette invention fusionnés à des séquences de polypeptides hétérologues, des anticorps qui se lient aux polypeptides de cette invention et des procédés de production desdits polypeptides.
CA002311640A 1997-12-03 1998-12-01 Polypeptides et acides nucleiques codant ces derniers Abandoned CA2311640A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002408167A CA2408167A1 (fr) 1997-12-03 1998-12-01 Polypeptides pro243 et acides nucleiques codant lesdits polypeptides
CA002404248A CA2404248C (fr) 1997-12-03 1998-12-01 Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides

Applications Claiming Priority (31)

Application Number Priority Date Filing Date Title
US6741197P 1997-12-03 1997-12-03
US60/067,411 1997-12-03
US6933497P 1997-12-11 1997-12-11
US6933597P 1997-12-11 1997-12-11
US6927897P 1997-12-11 1997-12-11
US60/069,278 1997-12-11
US60/069,335 1997-12-11
US60/069,334 1997-12-11
US6942597P 1997-12-12 1997-12-12
US60/069,425 1997-12-12
US6970297P 1997-12-16 1997-12-16
US6969697P 1997-12-16 1997-12-16
US6969497P 1997-12-16 1997-12-16
US60/069,694 1997-12-16
US60/069,696 1997-12-16
US60/069,702 1997-12-16
US6987097P 1997-12-17 1997-12-17
US6987397P 1997-12-17 1997-12-17
US60/069,873 1997-12-17
US60/069,870 1997-12-17
US6801797P 1997-12-18 1997-12-18
US60/068,017 1997-12-18
US7044098P 1998-01-05 1998-01-05
US60/070,440 1998-01-05
US7408698P 1998-02-09 1998-02-09
US7409298P 1998-02-09 1998-02-09
US60/074,086 1998-02-09
US60/074,092 1998-02-09
US7594598P 1998-02-25 1998-02-25
US60/075,945 1998-02-25
PCT/US1998/025108 WO1999028462A2 (fr) 1997-12-03 1998-12-01 Polypeptides et acides nucleiques codant ces derniers

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CA002404248A Division CA2404248C (fr) 1997-12-03 1998-12-01 Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
CA002408167A Division CA2408167A1 (fr) 1997-12-03 1998-12-01 Polypeptides pro243 et acides nucleiques codant lesdits polypeptides

Publications (1)

Publication Number Publication Date
CA2311640A1 true CA2311640A1 (fr) 1999-06-10

Family

ID=27585489

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002311640A Abandoned CA2311640A1 (fr) 1997-12-03 1998-12-01 Polypeptides et acides nucleiques codant ces derniers

Country Status (8)

Country Link
EP (1) EP1037979A2 (fr)
JP (3) JP2002505850A (fr)
KR (1) KR100386046B1 (fr)
AU (1) AU736506B2 (fr)
CA (1) CA2311640A1 (fr)
IL (4) IL136216A0 (fr)
NZ (5) NZ527899A (fr)
WO (1) WO1999028462A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
ES2264207T3 (es) * 1997-07-18 2006-12-16 Zymogenetics, Inc. Homonologos proteinicos especificos de adipocitos.
US6566499B1 (en) 1997-07-18 2003-05-20 Zymogenetics, Inc. Adipocyte-specific protein homologs
AU744254B2 (en) 1997-08-26 2002-02-21 Zymogenetics Inc. Adipocyte-specific protein homologs
US20030166188A1 (en) 1997-09-18 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2002505850A (ja) * 1997-12-03 2002-02-26 ジェネンテック・インコーポレーテッド ポリペプチド及び同じものをコードしている核酸
EP1064364A4 (fr) * 1998-03-23 2004-12-29 Smithkline Beecham Corp Element 2-21 de la famille des cytokines
US6001596A (en) * 1998-05-07 1999-12-14 Incyte Pharmaceuticals, Inc. Growth-associated protease inhibitor heavy chain precursor
CA2337100C (fr) * 1998-08-07 2011-09-20 Immunex Corporation Polypeptides des molecules d'adhesion des cellules dendritiques lymphoides (ldcam) et polynucleotides codant lesdits polypeptides
US6406884B1 (en) * 1999-06-18 2002-06-18 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
WO2000026244A2 (fr) * 1998-11-04 2000-05-11 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nouveau membre de la famille des facteurs de necrose des tumeurs, ligand du recepteur de la mort cellulaire (drl) et compositions et procedes correspondants
MXPA01005425A (es) * 1998-12-01 2002-04-24 Genentech Inc Polipeptidos de transmembrana y secretados y acidos nucleicos que codifican los mismos.
US6448221B1 (en) 1999-02-19 2002-09-10 Zymogenetics, Inc. Methods of promoting blood flow within the vasculature of a mammal
US6544946B1 (en) 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
US6800460B1 (en) 1999-03-11 2004-10-05 Schering Corporation Mammalian cytokine complexes
ATE420894T1 (de) * 1999-03-11 2009-01-15 Schering Corp Cytokine aus säugetieren, verwandte reagenzien und verfahren
US20030022233A1 (en) 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
EP1953173B1 (fr) * 1999-06-15 2009-11-18 Genentech, Inc. Polypeptides sécrétés et transmembranaires, et acides nucléiques les codant
EP1067182A3 (fr) * 1999-07-08 2001-11-21 Helix Research Institute Proteine secretoire ou proteine de membrane
US7129338B1 (en) 1999-07-08 2006-10-31 Research Association For Biotechnology Secretory protein or membrane protein
WO2001009162A2 (fr) * 1999-07-30 2001-02-08 Millennium Pharmaceuticals, Inc. Proteine secretees et leurs applications
US6566078B1 (en) 1999-10-28 2003-05-20 Agensys, Inc. 36P6D5: secreted tumor antigen
EP1686134A3 (fr) * 1999-12-01 2006-08-09 Genentech, Inc. Polypeptides transmembranaires et secrétés et les acides nucléiques codant ceux-ci
WO2001046229A1 (fr) * 1999-12-20 2001-06-28 Smithkline Beecham Corporation Membre de la famille des cytokines, 2-21 mur
GEP20063830B (en) * 2000-01-12 2006-05-25 Univ Yale Nogo Receptor-Mediated Blockade of Axonal Growth
AU2001261557B2 (en) 2000-05-12 2005-06-30 Amgen Inc. Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
EP1666491A1 (fr) * 2000-06-02 2006-06-07 Genentech, Inc. Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
WO2001096528A2 (fr) * 2000-06-15 2001-12-20 Human Genome Sciences, Inc. Facteur de necrose tumorale humain delta et epsilon
EP1312675B1 (fr) * 2000-08-09 2009-07-01 MARUHO Co., Ltd. Proteine induite par transfusion sanguine homogene et adn la codant
AU2001281254A1 (en) * 2000-08-10 2002-02-18 Pharmacia Corporation A new egf motif repeat protein obtained from a cdna library from hs-5 stromal cell line
AU2002311976A1 (en) 2001-05-24 2002-12-03 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (april)
EP1415997A4 (fr) * 2001-07-19 2005-03-30 Mitsubishi Pharma Corp Polypeptides se rapportant au transfert de signaux de recepteur de produits terminaux a glycation avancee
US7358349B2 (en) * 2001-08-24 2008-04-15 Hisamitsu Pharmaceutical Co., Inc. Nucleic acids having expression differentials between hepatoblastoma and normal liver
WO2003029467A1 (fr) * 2001-09-05 2003-04-10 Japan Science And Technology Corporation Candidate proteine pour nouveau facteur de polarisation cellulaire et polynucleotide codant cette proteine
AU2004261941B2 (en) 2003-07-25 2008-04-10 Amgen Inc. Antagonists and agonists of LDCAM and methods of use
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
CA2590461A1 (fr) 2004-12-23 2006-06-29 Laboratoires Serono S.A. Polypeptides bcma et leurs utilisations
AU2006318539B2 (en) 2005-11-23 2012-09-13 Genentech, Inc. Methods and compositions related to B cell assays
DK2069793T3 (en) 2006-08-29 2017-04-24 Oxford Biotherapeutics Ltd IDENTIFICATION OF PROTEIN IN CONNECTION WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER
HUE034196T2 (en) 2009-03-05 2018-02-28 Squibb & Sons Llc Fully human antibodies specific for CADM1

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
WO1991000360A1 (fr) 1989-06-29 1991-01-10 Medarex, Inc. Reactifs bispecifiques pour le traitement du sida
ATE253633T1 (de) * 1989-08-22 2003-11-15 Hsc Res Dev Corp Cystic fibrosis gen
WO1992020373A1 (fr) 1991-05-14 1992-11-26 Repligen Corporation Anticorps d'heteroconjugues pour le traitement des infections a l'hiv
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
AU6926194A (en) * 1994-05-09 1995-11-29 Boehringer Mannheim Gmbh Use of chondroitin sulphate proteoglycans for protection of neurons
WO1996014331A1 (fr) * 1994-11-07 1996-05-17 Merck & Co., Inc. Recepteurs neuropeptidiques y modifies
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
WO1997025427A1 (fr) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mpc-2)
AU8555698A (en) * 1997-08-01 1999-02-22 Genset 5' ests for secreted proteins expressed in various tissues
JP2002505850A (ja) * 1997-12-03 2002-02-26 ジェネンテック・インコーポレーテッド ポリペプチド及び同じものをコードしている核酸

Also Published As

Publication number Publication date
WO1999028462A9 (fr) 2001-05-31
KR20010032719A (ko) 2001-04-25
AU1602999A (en) 1999-06-16
WO1999028462A2 (fr) 1999-06-10
NZ527899A (en) 2004-10-29
NZ527900A (en) 2005-02-25
JP2003116588A (ja) 2003-04-22
KR100386046B1 (ko) 2003-06-02
JP3786909B2 (ja) 2006-06-21
IL178210A0 (en) 2006-12-31
AU736506B2 (en) 2001-07-26
JP2002505850A (ja) 2002-02-26
IL136216A (en) 2009-09-22
NZ522634A (en) 2004-02-27
IL197834A0 (en) 2009-12-24
IL136216A0 (en) 2001-05-20
NZ527898A (en) 2005-01-28
NZ504548A (en) 2003-06-30
JP2003116587A (ja) 2003-04-22
EP1037979A2 (fr) 2000-09-27
WO1999028462A3 (fr) 1999-10-14

Similar Documents

Publication Publication Date Title
AU736506B2 (en) Polypeptides and nucleic acids encoding the same
US7189566B2 (en) PRO347 nucleic acids
JP2003524387A (ja) 分泌及び膜貫通ポリペプチドとそれをコードする核酸
US20090170158A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7442772B2 (en) Antibodies to PRO361 polypeptide
US20050003487A1 (en) Chordin dorsalizing and hemoglobin inducing polypeptides and nucleic acids encoding the same
EP1209168B1 (fr) Polypeptides PRO243 et acides nucléotidiques les codant
US20060105427A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1191101B1 (fr) Polypeptides PRO241 et polynucleotides codant pour ces polypeptides
US7368558B2 (en) PRO357 nucleic acids
US7470771B2 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU4236802A (en) Polypeptides and nucleic acids encoding the same
CA2408167A1 (fr) Polypeptides pro243 et acides nucleiques codant lesdits polypeptides
US20050014225A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
MXPA00005354A (en) Polypeptides and nucleic acids encoding the same
ZA200103574B (en) Secreted and transmembrane polypeptides and nucleic acids and encoding the same.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued